ALISON BERNDT: Open Payments
NPI 1568834588 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,578 in 106 payments from 22 companies in 2025. Trend: 2023 $2,069 · 2024 $2,712 · 2025 $2,578
Food & beverage: $2,484Education: $95
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 26 | $622 |
| Regeneron Healthcare Solutions, Inc. | 7 | $251 |
| JAZZ PHARMACEUTICALS INC. | 8 | $239 |
| AstraZeneca Pharmaceuticals LP | 12 | $218 |
| Axsome Therapeutics, Inc. | 8 | $208 |
| Grifols USA, LLC | 5 | $134 |
| Viatris Specialty LLC | 5 | $122 |
| Insmed, Inc. | 5 | $119 |
| Baxter Healthcare | 3 | $102 |
| Verona Pharma, Inc. | 5 | $86 |
Products named: DUPIXENT, NUCALA, XYWAV, TRELEGY ELLIPTA, Sunosi, Prolastin-C Liquid, FASENRA, AREXVY.
Industry payments across MD — which companies pay providers there.
